| lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NPPA-AS1 | Middle East Respiratory Syndrome Coronavirus (EMC_2012 strain of (MERS-CoV)) | MOI = 3 ;
24 hr |
MRC-5 Human fetal lung fibroblast cells | RNA-Seq | 4.593073913 | Upregulation | 2.73E-10 | student's t test | 2020 | 32416070 | |
| NPPA-AS1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells | RNA-Seq | 0.452308809 | Downregulation | 0.004366933 | student's t test | 2020 | 32416070 | |
| NPPA-AS1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
Calu-3 Human adenocarcinomic lung epithelialcells | RNA-Seq | 0.337090997 | Downregulation | 0 | student's t test | 2020 | 32416070 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose